CALGARY, Alberta--(BUSINESS WIRE)--Userful Corporation, a leader in mission-critical data visualization, has been named Data Visualization Platform of the Year by CIO Review. This recognition ...
New service leverages proprietary technology to provide unprecedented insights into antibody autoreactivity for translational research and therapeutic development. BALTIMORE, September 17, ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced interim data from its Phase 2, double-blind, randomized, placebo-controlled study of saridegib (IPI-926 ...
-- Company to Host Conference Call Today at 8:30 a.m. ET -- Infinity Pharmaceuticals, Inc. INFI -50.75% today announced interim data from its double-blind, randomized, placebo-controlled Phase 2 study ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (INFI) today announced topline data from its Phase 2 study of retaspimycin hydrochloride (HCl), a potent and selective heat shock ...
Userful’s Infinity Platform modernizes workplace management with pervasive data. CALGARY, Alberta, February 19, 2025--(BUSINESS WIRE)--Userful Corporation, a leader in mission-critical data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback